Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Author:

Sarin Shiv KumarORCID, ,Choudhury Ashok,Lau George K.,Zheng Ming-Hua,Ji Dong,Abd-Elsalam Sherief,Hwang Jaeseok,Qi Xiaolong,Cua Ian Homer,Suh Jeong Ill,Park Jun Gi,Putcharoen Opass,Kaewdech Apichat,Piratvisuth Teerha,Treeprasertsuk Sombat,Park Sooyoung,Wejnaruemarn Salisa,Payawal Diana A.,Baatarkhuu Oidov,Ahn Sang Hoon,Yeo Chang Dong,Alonzo Uzziel Romar,Chinbayar Tserendorj,Loho Imelda M.,Yokosuka Osamu,Jafri Wasim,Tan Soeksiam,Soo Lau Ing,Tanwandee Tawesak,Gani Rino,Anand Lovkesh,Esmail Eslam Saber,Khalaf Mai,Alam Shahinul,Lin Chun-Yu,Chuang Wan-Long,Soin A. S.,Garg Hitendra K.,Kalista Kemal,Batsukh Badamnachin,Purnomo Hery Djagat,Dara Vijay Pal,Rathi Pravin,Al Mahtab Mamun,Shukla Akash,Sharma Manoj K.,Omata Masao

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Reference30 articles.

1. Coronavirus disease (COVID-19) Situation Report – 113. Data as received by WHO from national authorities. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200512-covid-19-sitrep-113.pdf?sfvrsn=feac3b6d_2 .

2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395(10224):565–574

3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032

4. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. https://doi.org/10.1016/s2213-2600(20)30079-5

5. Chen C, Zhang XR, Ju ZY, He WF. Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies. Zhonghua Shaoshang Zazhi 2020;36:E005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3